Protease inhibitors: recent advancement in its usage as a potential biocontrol agent for insect pest management S Singh, A Singh, S Kumar, P Mittal, IK Singh Insect science 27 (2), 186-201, 2020 | 100 | 2020 |
Plant cytochrome P450s: Role in stress tolerance and potential applications for human welfare A Singh, R Panwar, P Mittal, MI Hassan, IK Singh International Journal of Biological Macromolecules 184, 874-886, 2021 | 23 | 2021 |
Myeloid Cell Leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy P Mittal, S Singh, R Sinha, A Shrivastava, A Singh, IK Singh International journal of biological macromolecules, 2021 | 21 | 2021 |
Current advances in drug delivery systems for treatment of Triple negative breast cancer (TNBC) P Mittal, S Singh, A Singh, IK Singh Chemical Biology Letters 7 (1), 1-12, 2020 | 16 | 2020 |
Focusing on DNA repair and damage tolerance mechanisms in mycobacterium tuberculosis: an emerging therapeutic theme P Mittal, R Sinha, A Kumar, P Singh, MR Ngasainao, A Singh, IK Singh Current topics in medicinal chemistry 20 (5), 390-408, 2020 | 10 | 2020 |
Effects of pesticides on human physiology, genetics, and evolution P Karwal, P Mittal, G Nagar, A Singh, IK Singh Emerging Contaminants in the Environment 1, 287-310, 2022 | 4 | 2022 |
New entrants into clinical trials for targeted therapy of breast Cancer: an insight P Verma, P Mittal, A Singh, IK Singh Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 4 | 2019 |
Emerging Therapeutic Approaches to COVID-19 IK Singh, P Kumari, P Mittal, A Kumar, B Singal, GM Hasan, R Aggarwal, ... Current Pharmaceutical Design 27 (31), 3370-3388, 2021 | 3 | 2021 |
Breast Cancer Therapeutics and Hippo Signaling Pathway: Novel MicroRNA-Gene-Protein Interaction Networks SRR Gupta, G Nagar, P Mittal, S Rana, H Singh, R Singh, A Singh, ... OMICS: A Journal of Integrative Biology 27 (6), 273-280, 2023 | 1 | 2023 |
Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting G Nagar, P Mittal, SRR Gupta, M Pahuja, M Sanger, R Mishra, A Singh, ... Briefings in Functional Genomics 22 (2), 123-142, 2023 | 1 | 2023 |
SETD2 gene expression and the molecular landscape of colorectal cancer (CRC). F Battaglin, H Krause, A Elliot, J Abraham, S Soni, S Algaze, ... Journal of Clinical Oncology 41 (4_suppl), 184-184, 2023 | 1 | 2023 |
Receptor tyrosine kinase-like orphan receptors ROR1/2: Insights into the mechanism of action, inhibition, and therapeutic potential V Rustagi, G Nagar, P Mittal, A Singh, IK Singh Protein Kinase Inhibitors, 597-621, 2022 | 1 | 2022 |
Genome-wide association study (GWAS) and novel prognostic markers in metastatic colorectal cancer (mCRC). Y Yang, F Battaglin, S Soni, S Algaze, JH Lo, P Mittal, L Torres-Gonzalez, ... Journal of Clinical Oncology 42 (3_suppl), 174-174, 2024 | | 2024 |
Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI … A Wong, N Gandhi, J Xiu, S Algaze, P Jayachandran, K Ashouri, S Soni, ... Journal of Clinical Oncology 42 (3_suppl), 190-190, 2024 | | 2024 |
Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial. S Algaze, Y Yang, J Millstein, S Soni, F Battaglin, P Jayachandran, JH Lo, ... Journal of Clinical Oncology 42 (3_suppl), 198-198, 2024 | | 2024 |
LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC). L Torres-Gonzalez, F Battaglin, S Soni, Y Baca, J Xiu, P Walker, JH Lo, ... Journal of Clinical Oncology 42 (3_suppl), 172-172, 2024 | | 2024 |
Identification and characterization of immunogenic neoantigens in colorectal cancer (CRC). F Battaglin, A Elliott, J Xiu, S Algaze, J Wang, P Jayachandran, S Soni, ... Journal of Clinical Oncology 42 (3_suppl), 161-161, 2024 | | 2024 |
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma. K Ashouri, Y Baca, J Xiu, S Soni, P Mittal, S Algaze, P Jayachandran, ... Journal of Clinical Oncology 42 (3_suppl), 699-699, 2024 | | 2024 |
Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC). F Battaglin, A Elliott, J Xiu, S Algaze, J Wang, P Jayachandran, S Soni, ... Journal of Clinical Oncology 42 (3_suppl), 552-552, 2024 | | 2024 |
Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC). K Ashouri, Y Yang, J Millstein, S Stintzing, AR Parikh, S Soni, S Algaze, ... Journal of Clinical Oncology 42 (3_suppl), 188-188, 2024 | | 2024 |